메뉴 건너뛰기




Volumn 39, Issue 1, 2015, Pages 118-128

Solvent/detergent plasma: pharmaceutical characteristics and clinical experience

Author keywords

Clinical efficacy; Cost effectiveness; Fresh frozen plasma; Solvent detergent plasma; Transfusion related acute lung injury; Viral inactivation

Indexed keywords

DETERGENT; SOLVENT;

EID: 84927562038     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1086-1     Document Type: Review
Times cited : (27)

References (95)
  • 1
    • 0022382844 scopus 로고
    • Inactivation of viruses in labile blood derivatives: disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations
    • COI: 1:CAS:528:DyaL28Xls1altg%3D%3D, PID: 3934801
    • Horowitz B, Wiebe ME, Lippin A, Stryer MH (1985) Inactivation of viruses in labile blood derivatives: disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 25:516–522
    • (1985) Transfusion , vol.25 , pp. 516-522
    • Horowitz, B.1    Wiebe, M.E.2    Lippin, A.3    Stryer, M.H.4
  • 2
    • 0023058814 scopus 로고
    • Sterilization of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate
    • COI: 1:CAS:528:DyaL28XitFejtbs%3D, PID: 2870224
    • Prince AM, Horowitz B, Brotman B (1986) Sterilization of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate. Lancet 1:706–710
    • (1986) Lancet , vol.1 , pp. 706-710
    • Prince, A.M.1    Horowitz, B.2    Brotman, B.3
  • 3
    • 69249170993 scopus 로고    scopus 로고
    • Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Therapeutics Association member companies
    • PID: 19497061
    • Dichtelmüller HO, Biesert L, Fabbrizzi F et al (2009) Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Therapeutics Association member companies. Transfusion 49:1931–1943
    • (2009) Transfusion , vol.49 , pp. 1931-1943
    • Dichtelmüller, H.O.1    Biesert, L.2    Fabbrizzi, F.3
  • 4
    • 0015258068 scopus 로고
    • Characterization of subviral components resulting from treatment of rabies virus with tri(n-buty1)phosphate
    • COI: 1:CAS:528:DyaE38XhsV2ntLc%3D, PID: 5011265
    • Neurath AR, Vernon SK, Dobkin MB, Rubin BA (1972) Characterization of subviral components resulting from treatment of rabies virus with tri(n-buty1)phosphate. J Gen Virol 14:33–48
    • (1972) J Gen Virol , vol.14 , pp. 33-48
    • Neurath, A.R.1    Vernon, S.K.2    Dobkin, M.B.3    Rubin, B.A.4
  • 5
    • 79952196987 scopus 로고    scopus 로고
    • Data management and data integration in the HUPO plasma proteome project
    • COI: 1:CAS:528:DC%2BC3cXhsFyjsrnE, PID: 21063952
    • Omenn GS (2011) Data management and data integration in the HUPO plasma proteome project. Methods Mol Biol 696:247–257
    • (2011) Methods Mol Biol , vol.696 , pp. 247-257
    • Omenn, G.S.1
  • 6
    • 79851482225 scopus 로고    scopus 로고
    • The use of solvent/detergent treatment in pathogen reduction of plasma
    • PID: 21779207
    • Hellstern P, Solheim BG (2011) The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 38:65–70
    • (2011) Transfus Med Hemother , vol.38 , pp. 65-70
    • Hellstern, P.1    Solheim, B.G.2
  • 7
    • 0026669973 scopus 로고
    • Manufacture and in vitro characterization of solvent/detergent-treated plasma
    • COI: 1:CAS:528:DyaK3sXksFGmsQ%3D%3D, PID: 1448962
    • Hellstern P, Sachse H, Schwinn H, Oberfrank K (1992) Manufacture and in vitro characterization of solvent/detergent-treated plasma. Vox Sang 63:178–185
    • (1992) Vox Sang , vol.63 , pp. 178-185
    • Hellstern, P.1    Sachse, H.2    Schwinn, H.3    Oberfrank, K.4
  • 8
    • 0026543642 scopus 로고
    • Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma
    • COI: 1:STN:280:DyaK387hvFejuw%3D%3D, PID: 1310064
    • Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW (1992) Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma. Blood 79:826–833
    • (1992) Blood , vol.79 , pp. 826-833
    • Horowitz, B.1    Bonomo, R.2    Prince, A.M.3    Chin, S.N.4    Brotman, B.5    Shulman, R.W.6
  • 9
    • 0031853914 scopus 로고    scopus 로고
    • Solvent/detergent treatment of human plasma: a very robust method for virus inactivation. Validation of virus safety of Octaplas
    • COI: 1:CAS:528:DyaK1cXkvFCitr8%3D, PID: 9789530
    • Biesert L, Shartono H (1998) Solvent/detergent treatment of human plasma: a very robust method for virus inactivation. Validation of virus safety of Octaplas. Vox Sang 74(Suppl 1):207–212
    • (1998) Vox Sang , vol.74 , pp. 207-212
    • Biesert, L.1    Shartono, H.2
  • 10
    • 62349127703 scopus 로고    scopus 로고
    • Properties of pathogen-inactivated plasma components
    • PID: 19304113
    • Prowse C (2009) Properties of pathogen-inactivated plasma components. Transfus Med Rev 23:124–133
    • (2009) Transfus Med Rev , vol.23 , pp. 124-133
    • Prowse, C.1
  • 13
    • 33751360613 scopus 로고    scopus 로고
    • A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable bag system
    • COI: 1:CAS:528:DC%2BD2sXns1KmsQ%3D%3D, PID: 17176321
    • Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M (2006) A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable bag system. Transfusion 46:2100–2108
    • (2006) Transfusion , vol.46 , pp. 2100-2108
    • Burnouf, T.1    Goubran, H.A.2    Radosevich, M.3    Sayed, M.A.4    Gorgy, G.5    El-Ekiaby, M.6
  • 14
    • 74049149907 scopus 로고    scopus 로고
    • Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
    • COI: 1:STN:280:DC%2BC3c3kslaitQ%3D%3D, PID: 19778318
    • El-Ekiaby M, Sayed MA, Caron C et al (2010) Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfus Med 20:48–61
    • (2010) Transfus Med , vol.20 , pp. 48-61
    • El-Ekiaby, M.1    Sayed, M.A.2    Caron, C.3
  • 15
    • 84883896424 scopus 로고    scopus 로고
    • Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers
    • COI: 1:CAS:528:DC%2BC3sXhsVCgt7fF, PID: 23320451
    • Jilma-Stohlawetz P, Kursten FW, Horvath M et al (2013) Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers. Transfusion 53:1906–1917
    • (2013) Transfusion , vol.53 , pp. 1906-1917
    • Jilma-Stohlawetz, P.1    Kursten, F.W.2    Horvath, M.3
  • 16
    • 70349527966 scopus 로고    scopus 로고
    • Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time
    • COI: 1:CAS:528:DC%2BD1MXht1OqsL%2FI, PID: 19392784
    • Heger A, Svae TE, Neisser-Svae A, Jordan S, Behizad M, Römisch J (2009) Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time. Vox Sang 97:219–225
    • (2009) Vox Sang , vol.97 , pp. 219-225
    • Heger, A.1    Svae, T.E.2    Neisser-Svae, A.3    Jordan, S.4    Behizad, M.5    Römisch, J.6
  • 17
    • 47749155632 scopus 로고    scopus 로고
    • Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma
    • PID: 18661921
    • Liumbruno GM, Sodini ML, Grazzini G, Tuscan Transfusion System (2008) Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 6:25–36
    • (2008) Blood Transfus , vol.6 , pp. 25-36
    • Liumbruno, G.M.1    Sodini, M.L.2    Grazzini, G.3    Tuscan Transfusion System4
  • 18
    • 0033792014 scopus 로고    scopus 로고
    • Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma
    • COI: 1:STN:280:DC%2BD3crhtVSrug%3D%3D, PID: 11061856
    • Koenigbauer UF, Eastlund T, Day JW (2000) Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 40:1203–1206
    • (2000) Transfusion , vol.40 , pp. 1203-1206
    • Koenigbauer, U.F.1    Eastlund, T.2    Day, J.W.3
  • 19
    • 66349101982 scopus 로고    scopus 로고
    • Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components
    • PID: 19503628
    • Liumbruno GM, Catalano L, Piccinini V, Pupella S, Grazzini G (2009) Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components. Blood Transfus 7:86–93
    • (2009) Blood Transfus , vol.7 , pp. 86-93
    • Liumbruno, G.M.1    Catalano, L.2    Piccinini, V.3    Pupella, S.4    Grazzini, G.5
  • 20
    • 84859853766 scopus 로고    scopus 로고
    • Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria
    • COI: 1:CAS:528:DC%2BC38Xptl2isbY%3D, PID: 22092109
    • Chou ML, Wu YW, Su CY, Lee LW, Burnouf T (2012) Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria. Vox Sang 102:277–284
    • (2012) Vox Sang , vol.102 , pp. 277-284
    • Chou, M.L.1    Wu, Y.W.2    Su, C.Y.3    Lee, L.W.4    Burnouf, T.5
  • 21
    • 0033668693 scopus 로고    scopus 로고
    • Solvent-detergent fresh frozen plasma. A superior alternative to standard fresh frozen plasma?
    • COI: 1:STN:280:DC%2BD3M7lt1Oiuw%3D%3D, PID: 11139117
    • Sharma AD, Sreeram D, Erb T, Grocott HP (2000) Solvent-detergent fresh frozen plasma. A superior alternative to standard fresh frozen plasma? J Cardiothorac Vasc Anesth 14:712–717
    • (2000) J Cardiothorac Vasc Anesth , vol.14 , pp. 712-717
    • Sharma, A.D.1    Sreeram, D.2    Erb, T.3    Grocott, H.P.4
  • 22
    • 13544277096 scopus 로고    scopus 로고
    • Solvent/detergent-treated plasma: composition, efficacy, and safety
    • COI: 1:CAS:528:DC%2BD2cXhtVWktbfL, PID: 15666659
    • Hellstern P (2004) Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 11:346–350
    • (2004) Curr Opin Hematol , vol.11 , pp. 346-350
    • Hellstern, P.1
  • 23
    • 33748475913 scopus 로고    scopus 로고
    • Update on pathogen reduction technology for therapeutic plasma: an overview
    • COI: 1:STN:280:DC%2BD28rlsFCitg%3D%3D, PID: 16934528
    • Solheim BG, Seghatchian J (2006) Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 35:83–90
    • (2006) Transfus Apher Sci , vol.35 , pp. 83-90
    • Solheim, B.G.1    Seghatchian, J.2
  • 24
    • 0026493740 scopus 로고
    • Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results
    • COI: 1:STN:280:DyaK3s7islGqsA%3D%3D, PID: 1336258
    • Piquet Y, Janvier G, Selosse P et al (1992) Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results. Vox Sang 63:251–256
    • (1992) Vox Sang , vol.63 , pp. 251-256
    • Piquet, Y.1    Janvier, G.2    Selosse, P.3
  • 25
    • 9644303469 scopus 로고    scopus 로고
    • Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas)
    • COI: 1:CAS:528:DC%2BD2MXitFyisQ%3D%3D, PID: 15548265
    • Sinnott P, Bodger S, Gupta A, Brophy M (2004) Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet 31:271–274
    • (2004) Eur J Immunogenet , vol.31 , pp. 271-274
    • Sinnott, P.1    Bodger, S.2    Gupta, A.3    Brophy, M.4
  • 26
    • 27744588912 scopus 로고    scopus 로고
    • White blood cell reactive antibodies are undetectable in solvent/detergent plasma
    • PID: 16181214
    • Sachs UJ, Kauschat D, Bein G (2005) White blood cell reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 45:1628–1631
    • (2005) Transfusion , vol.45 , pp. 1628-1631
    • Sachs, U.J.1    Kauschat, D.2    Bein, G.3
  • 27
    • 0037293170 scopus 로고    scopus 로고
    • The Norwegian Plasma Fractionation Project: a 12-year clinical and economic success story
    • COI: 1:STN:280:DC%2BD3s7gvVyqsg%3D%3D, PID: 12620274
    • Flesland O, Seghatchian J, Solheim BG (2003) The Norwegian Plasma Fractionation Project: a 12-year clinical and economic success story. Transfus Apher Sci 28:93–100
    • (2003) Transfus Apher Sci , vol.28 , pp. 93-100
    • Flesland, O.1    Seghatchian, J.2    Solheim, B.G.3
  • 28
    • 84888432559 scopus 로고    scopus 로고
    • Eight years with haemovigilance in Norway. What have we learnt?
    • PID: 24157220
    • Steinsvåg CT, Espinosa A, Flesland O (2013) Eight years with haemovigilance in Norway. What have we learnt? Transfus Apher Sci 49:548–552
    • (2013) Transfus Apher Sci , vol.49 , pp. 548-552
    • Steinsvåg, C.T.1    Espinosa, A.2    Flesland, O.3
  • 29
    • 84878249988 scopus 로고    scopus 로고
    • Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS: a pilot study
    • COI: 1:CAS:528:DC%2BC3sXhtV2rtr4%3D, PID: 23338984
    • Thevis M, Krug O, Geyer H et al (2013) Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS: a pilot study. Drug Test Anal 5:380–383
    • (2013) Drug Test Anal , vol.5 , pp. 380-383
    • Thevis, M.1    Krug, O.2    Geyer, H.3
  • 30
    • 78049266816 scopus 로고    scopus 로고
    • Anaerobic storage of red blood cells
    • PID: 20967163
    • Yoshida T, Shevkoplyas SS (2010) Anaerobic storage of red blood cells. Blood Transfus 8:220–236
    • (2010) Blood Transfus , vol.8 , pp. 220-236
    • Yoshida, T.1    Shevkoplyas, S.S.2
  • 31
    • 84898816839 scopus 로고    scopus 로고
    • Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion
    • COI: 1:CAS:528:DC%2BC2cXmvV2js74%3D, PID: 24460692
    • Feys HB, Van Aelst B, Devreese K et al (2014) Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion. Vox Sang 106:307–315
    • (2014) Vox Sang , vol.106 , pp. 307-315
    • Feys, H.B.1    Van Aelst, B.2    Devreese, K.3
  • 32
    • 84880703877 scopus 로고    scopus 로고
    • Update on the use of pathogen-reduced human plasma and platelet concentrates
    • COI: 1:CAS:528:DC%2BC3sXhtFOitrnN, PID: 23710899
    • Seltsam A, Müller TH (2013) Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 162:442–454
    • (2013) Br J Haematol , vol.162 , pp. 442-454
    • Seltsam, A.1    Müller, T.H.2
  • 33
    • 52049111879 scopus 로고    scopus 로고
    • Quality control of recovered plasma for fractionation: an extensive Italian study
    • COI: 1:CAS:528:DC%2BD1cXpt1emsLY%3D, PID: 18435675
    • Grazzini G, Rossi G, Rafanelli D et al (2008) Quality control of recovered plasma for fractionation: an extensive Italian study. Transfusion 48:1459–1468
    • (2008) Transfusion , vol.48 , pp. 1459-1468
    • Grazzini, G.1    Rossi, G.2    Rafanelli, D.3
  • 34
    • 33847616443 scopus 로고    scopus 로고
    • Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development
    • COI: 1:CAS:528:DC%2BD2sXkvFens7w%3D, PID: 17348869
    • Heger A, Kannicht C, Römisch J, Svae TE (2007) Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development. Vox Sang 92:206–212
    • (2007) Vox Sang , vol.92 , pp. 206-212
    • Heger, A.1    Kannicht, C.2    Römisch, J.3    Svae, T.E.4
  • 36
    • 0037379294 scopus 로고    scopus 로고
    • Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas)
    • PID: 12651690, author reply 1231–1232
    • Solheim BG, Bergan A, Brosstad F, Innes R, Svennevig JL (2003) Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas). Anesth Analg 96:1230–1231 author reply 1231–1232
    • (2003) Anesth Analg , vol.96 , pp. 1230-1231
    • Solheim, B.G.1    Bergan, A.2    Brosstad, F.3    Innes, R.4    Svennevig, J.L.5
  • 37
    • 0031823643 scopus 로고    scopus 로고
    • In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma
    • COI: 1:CAS:528:DyaK1cXkvFCitr0%3D, PID: 9789532
    • Beeck H, Hellstern P (1998) In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma. Vox Sang 74(Suppl 1):219–223
    • (1998) Vox Sang , vol.74 , pp. 219-223
    • Beeck, H.1    Hellstern, P.2
  • 38
    • 34249717261 scopus 로고    scopus 로고
    • Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas)
    • PID: 17544896
    • Magner JJ, Crowley KJ, Boylan JF (2007) Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth 21:410–413
    • (2007) J Cardiothorac Vasc Anesth , vol.21 , pp. 410-413
    • Magner, J.J.1    Crowley, K.J.2    Boylan, J.F.3
  • 39
    • 34848864313 scopus 로고    scopus 로고
    • It is time to bring back solvent-detergent plasma
    • PID: 17898568
    • Sandler SG (2007) It is time to bring back solvent-detergent plasma. Curr Opin Hematol 14:640–641
    • (2007) Curr Opin Hematol , vol.14 , pp. 640-641
    • Sandler, S.G.1
  • 40
    • 33746460956 scopus 로고    scopus 로고
    • Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?
    • COI: 1:STN:280:DC%2BD28vlslKltQ%3D%3D, PID: 16879155
    • Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, Seitz R, Heiden M (2006) Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? Transfus Med 16:266–275
    • (2006) Transfus Med , vol.16 , pp. 266-275
    • Salge-Bartels, U.1    Breitner-Ruddock, S.2    Hunfeld, A.3    Seitz, R.4    Heiden, M.5
  • 41
    • 2942624020 scopus 로고    scopus 로고
    • Acute hyperphosphatemia after plasma exchange with S/D-treated plasma
    • PID: 15157269
    • Thiéry G, Jacobs F, Bussel A et al (2004) Acute hyperphosphatemia after plasma exchange with S/D-treated plasma. Transfusion 44:947–948
    • (2004) Transfusion , vol.44 , pp. 947-948
    • Thiéry, G.1    Jacobs, F.2    Bussel, A.3
  • 42
    • 0033857903 scopus 로고    scopus 로고
    • Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?
    • COI: 1:STN:280:DC%2BD3cvlvVGhtw%3D%3D, PID: 10962468
    • Flamholz R, Jeon HR, Baron JM, Baron BW (2000) Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? J Clin Apher 15:169–172
    • (2000) J Clin Apher , vol.15 , pp. 169-172
    • Flamholz, R.1    Jeon, H.R.2    Baron, J.M.3    Baron, B.W.4
  • 43
    • 0037600705 scopus 로고    scopus 로고
    • Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura
    • PID: 12780794
    • Yarranton H, Cohen H, Pavord SR, Benjamin S, Hagger D, Machin SJ (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 121:778–785
    • (2003) Br J Haematol , vol.121 , pp. 778-785
    • Yarranton, H.1    Cohen, H.2    Pavord, S.R.3    Benjamin, S.4    Hagger, D.5    Machin, S.J.6
  • 44
    • 0033843210 scopus 로고    scopus 로고
    • Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–haemolytic–uremic syndrome
    • COI: 1:STN:280:DC%2BD3cvjtFKmsw%3D%3D, PID: 10960513
    • Rizvi MA, Vesely JN, George JN et al (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–haemolytic–uremic syndrome. Transfusion 40:896–901
    • (2000) Transfusion , vol.40 , pp. 896-901
    • Rizvi, M.A.1    Vesely, J.N.2    George, J.N.3
  • 45
    • 0037342954 scopus 로고    scopus 로고
    • Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: a study of 78 additional patients
    • PID: 12675731
    • McMinn JR Jr, Thomas IA, Terrel DR, Duvall D, Vesely SK, George JN (2003) Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: a study of 78 additional patients. Transfusion 43:415–416
    • (2003) Transfusion , vol.43 , pp. 415-416
    • McMinn, J.R.1    Thomas, I.A.2    Terrel, D.R.3    Duvall, D.4    Vesely, S.K.5    George, J.N.6
  • 46
    • 78651284022 scopus 로고    scopus 로고
    • A comparison of methods of pathogen inactivation of FFP
    • COI: 1:CAS:528:DC%2BC3MXisV2muro%3D, PID: 20667071
    • Rock G (2011) A comparison of methods of pathogen inactivation of FFP. Vox Sang 100:169–178
    • (2011) Vox Sang , vol.100 , pp. 169-178
    • Rock, G.1
  • 47
    • 84882303170 scopus 로고    scopus 로고
    • Current methods for the reduction of blood-borne pathogens: a comprehensive literature review
    • PID: 23522896
    • Picker SM (2013) Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfus 11:343–348
    • (2013) Blood Transfus , vol.11 , pp. 343-348
    • Picker, S.M.1
  • 48
    • 84861119185 scopus 로고    scopus 로고
    • Plasma components: properties, differences, and uses
    • COI: 1:CAS:528:DC%2BC38XpvVSitrY%3D, PID: 22578375
    • Benjamin RJ, McLaughlin LS (2012) Plasma components: properties, differences, and uses. Transfusion 52(Suppl):9S–19S
    • (2012) Transfusion , vol.52 , pp. 9S-19S
    • Benjamin, R.J.1    McLaughlin, L.S.2
  • 49
    • 84859837359 scopus 로고    scopus 로고
    • Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas
    • COI: 1:CAS:528:DC%2BC38Xptl2itrk%3D, PID: 22092160
    • Hacquard M, Lecompte T, Belcour B et al (2012) Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas. Vox Sang 102:354–361
    • (2012) Vox Sang , vol.102 , pp. 354-361
    • Hacquard, M.1    Lecompte, T.2    Belcour, B.3
  • 50
    • 33746572800 scopus 로고    scopus 로고
    • Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
    • COI: 1:CAS:528:DC%2BD28XnsFartbY%3D, PID: 16836564
    • Singh Y, Sawyer LS, Pinkoski LS et al (2006) Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 46:1168–1177
    • (2006) Transfusion , vol.46 , pp. 1168-1177
    • Singh, Y.1    Sawyer, L.S.2    Pinkoski, L.S.3
  • 51
    • 77950239200 scopus 로고    scopus 로고
    • Protein quality in Mirasol pathogen reduction technology–treated, apheresis-derived fresh-frozen plasma
    • COI: 1:CAS:528:DC%2BC3cXls12ltb8%3D, PID: 20051060
    • Smith J, Rock G (2010) Protein quality in Mirasol pathogen reduction technology–treated, apheresis-derived fresh-frozen plasma. Transfusion 50:926–931
    • (2010) Transfusion , vol.50 , pp. 926-931
    • Smith, J.1    Rock, G.2
  • 52
    • 0034490673 scopus 로고    scopus 로고
    • The effect of virus inactivation on coagulation factors in therapeutic plasma
    • COI: 1:STN:280:DC%2BD3M7hvFWisA%3D%3D, PID: 11122166
    • Zeiler T, Wittmann G, Zimmermann R, Hintz G, Huhn D, Riess H (2000) The effect of virus inactivation on coagulation factors in therapeutic plasma. Br J Haematol 111:986–987
    • (2000) Br J Haematol , vol.111 , pp. 986-987
    • Zeiler, T.1    Wittmann, G.2    Zimmermann, R.3    Hintz, G.4    Huhn, D.5    Riess, H.6
  • 53
    • 0038057391 scopus 로고    scopus 로고
    • Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma
    • COI: 1:CAS:528:DC%2BD3sXivFSitrg%3D, PID: 12695752
    • Doyle S, O’Brien P, Murphy K, Fleming C, O’Donnell J (2003) Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 14:283–287
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 283-287
    • Doyle, S.1    O’Brien, P.2    Murphy, K.3    Fleming, C.4    O’Donnell, J.5
  • 54
    • 0032776380 scopus 로고    scopus 로고
    • Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma
    • COI: 1:CAS:528:DyaK1MXkvFaksbk%3D, PID: 10413283
    • Aznar JA, Molina R, Montoro JM (1999) Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma. Transfusion 39:748–750
    • (1999) Transfusion , vol.39 , pp. 748-750
    • Aznar, J.A.1    Molina, R.2    Montoro, J.M.3
  • 55
    • 37549049779 scopus 로고    scopus 로고
    • Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen
    • COI: 1:CAS:528:DC%2BD1cXisVygtL0%3D, PID: 17900283
    • Osselaer JC, Debry C, Goffaux M et al (2008) Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 48:108–117
    • (2008) Transfusion , vol.48 , pp. 108-117
    • Osselaer, J.C.1    Debry, C.2    Goffaux, M.3
  • 56
    • 1842715059 scopus 로고    scopus 로고
    • Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
    • COI: 1:STN:280:DC%2BD2c7lt1CitQ%3D%3D, PID: 15043592
    • Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 14:39–44
    • (2004) Transfus Med , vol.14 , pp. 39-44
    • Yarranton, H.1    Lawrie, A.S.2    Purdy, G.3    Mackie, I.J.4    Machin, S.J.5
  • 57
    • 41149163375 scopus 로고    scopus 로고
    • Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers
    • COI: 1:CAS:528:DC%2BD1cXltlWiu78%3D, PID: 18194378
    • Schlenke P, Hervig T, Isola H et al (2008) Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 48:697–705
    • (2008) Transfusion , vol.48 , pp. 697-705
    • Schlenke, P.1    Hervig, T.2    Isola, H.3
  • 58
    • 71549147205 scopus 로고    scopus 로고
    • The influence of riboflavin photochemistry on plasma coagulation factors
    • PID: 19782644
    • Larrea L, Calabuig M, Roldan V et al (2009) The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci 41:199–204
    • (2009) Transfus Apher Sci , vol.41 , pp. 199-204
    • Larrea, L.1    Calabuig, M.2    Roldan, V.3
  • 59
    • 0027326230 scopus 로고
    • Evaluation of solvent/detergent treated plasma in the management of patients with acquired coagulation disorders
    • Inbal A, Epstein O, Blickstein D, Kombrot N, Brenner B, Martinowitz U (1993) Evaluation of solvent/detergent treated plasma in the management of patients with acquired coagulation disorders. Blood Coagul Fibrinolysis 4:559–604
    • (1993) Blood Coagul Fibrinolysis , vol.4 , pp. 559-604
    • Inbal, A.1    Epstein, O.2    Blickstein, D.3    Kombrot, N.4    Brenner, B.5    Martinowitz, U.6
  • 60
    • 0031850598 scopus 로고    scopus 로고
    • SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available
    • COI: 1:CAS:528:DyaK1cXkvFCitrs%3D, PID: 9789534
    • Horowitz MS, Pehta JC (1998) SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang 74(Suppl 1):231–235
    • (1998) Vox Sang , vol.74 , pp. 231-235
    • Horowitz, M.S.1    Pehta, J.C.2
  • 61
    • 33744499442 scopus 로고    scopus 로고
    • Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy
    • PID: 16670069
    • Santagostino E, Mancuso ME, Morfini M et al (2006) Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 91:634–639
    • (2006) Haematologica , vol.91 , pp. 634-639
    • Santagostino, E.1    Mancuso, M.E.2    Morfini, M.3
  • 62
    • 1842610163 scopus 로고    scopus 로고
    • Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients
    • PID: 15015971
    • Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69–73
    • (2004) Br J Haematol , vol.125 , pp. 69-73
    • Chowdhury, P.1    Saayman, A.G.2    Paulus, U.3    Findlay, G.P.4    Collins, P.W.5
  • 63
    • 33745783733 scopus 로고    scopus 로고
    • Toward rational fresh frozen plasma transfusion
    • PID: 16753596
    • Holland LL, Brooks JP (2006) Toward rational fresh frozen plasma transfusion. Am J Clin Pathol 126:133–139
    • (2006) Am J Clin Pathol , vol.126 , pp. 133-139
    • Holland, L.L.1    Brooks, J.P.2
  • 64
    • 61849136778 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
    • COI: 1:STN:280:DC%2BD1M3hsVWltQ%3D%3D, PID: 19222477
    • Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145:24–33
    • (2009) Br J Haematol , vol.145 , pp. 24-33
    • Levi, M.1    Toh, C.H.2    Thachil, J.3    Watson, H.G.4
  • 67
    • 0033674115 scopus 로고    scopus 로고
    • Evaluation of solvent/detergent treated plasma in patients with a prolonged prothrombin time
    • COI: 1:CAS:528:DC%2BD3cXptVeiurw%3D, PID: 11111235
    • Lerner RG, Nelson J, Sorcia E (2000) Evaluation of solvent/detergent treated plasma in patients with a prolonged prothrombin time. Vox Sang 79:161–167
    • (2000) Vox Sang , vol.79 , pp. 161-167
    • Lerner, R.G.1    Nelson, J.2    Sorcia, E.3
  • 68
  • 69
    • 0032740602 scopus 로고    scopus 로고
    • A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation
    • COI: 1:STN:280:DC%2BD3c%2FmslOguw%3D%3D, PID: 10604250
    • Williamson LM, Llewelyn CA, Fisher NC et al (1999) A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 39:1227–1234
    • (1999) Transfusion , vol.39 , pp. 1227-1234
    • Williamson, L.M.1    Llewelyn, C.A.2    Fisher, N.C.3
  • 70
    • 33749361738 scopus 로고    scopus 로고
    • Universal pathogen-reduced plasma in elective open-heart surgery and liver resection
    • PID: 16988101
    • Solheim BG (2006) Universal pathogen-reduced plasma in elective open-heart surgery and liver resection. Clin Med Res 4:209–217
    • (2006) Clin Med Res , vol.4 , pp. 209-217
    • Solheim, B.G.1
  • 71
    • 20544468386 scopus 로고    scopus 로고
    • Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection
    • COI: 1:STN:280:DC%2BD2M3psVCktw%3D%3D, PID: 15938736
    • Solheim BG, Granov DA, Juravlev VA et al (2005) Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection. Vox Sang 89:19–26
    • (2005) Vox Sang , vol.89 , pp. 19-26
    • Solheim, B.G.1    Granov, D.A.2    Juravlev, V.A.3
  • 72
    • 33745001461 scopus 로고    scopus 로고
    • Solvent–detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies
    • COI: 1:STN:280:DC%2BD283hvVaqsg%3D%3D, PID: 16623914
    • Chekrizova V, Murphy WG (2006) Solvent–detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transfus Med 16:85–91
    • (2006) Transfus Med , vol.16 , pp. 85-91
    • Chekrizova, V.1    Murphy, W.G.2
  • 73
    • 7344246551 scopus 로고    scopus 로고
    • A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation
    • COI: 1:CAS:528:DyaK1cXkvFCitro%3D, PID: 9789533
    • Freeman JW, Williamson LM, Llewelyn C et al (1998) A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation. Vox Sang 74(Suppl 1):225–229
    • (1998) Vox Sang , vol.74 , pp. 225-229
    • Freeman, J.W.1    Williamson, L.M.2    Llewelyn, C.3
  • 74
    • 84880298407 scopus 로고    scopus 로고
    • Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study
    • COI: 1:CAS:528:DC%2BC3sXhtFSrurnO, PID: 23448618
    • Bindi ML, Miccoli M, Marietta M et al (2013) Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study. Vox Sang 105:137–143
    • (2013) Vox Sang , vol.105 , pp. 137-143
    • Bindi, M.L.1    Miccoli, M.2    Marietta, M.3
  • 75
    • 84876368074 scopus 로고    scopus 로고
    • Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy
    • PID: 23548954
    • Lepri D, Capuzzo E, Mattioli AV et al (2013) Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy. Recenti Prog Med 104:106–111
    • (2013) Recenti Prog Med , vol.104 , pp. 106-111
    • Lepri, D.1    Capuzzo, E.2    Mattioli, A.V.3
  • 76
    • 0002371605 scopus 로고    scopus 로고
    • Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery
    • COI: 1:CAS:528:DC%2BD38Xht1Wltbg%3D, PID: 11856461
    • Haubelt H, Blome M, Kiessling AH et al (2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 82:9–14
    • (2002) Vox Sang , vol.82 , pp. 9-14
    • Haubelt, H.1    Blome, M.2    Kiessling, A.H.3
  • 77
    • 0010692251 scopus 로고    scopus 로고
    • Prospective randomized and controlled study on solvent/detergent versus methylene blue/light virus-inactivated plasma
    • Wieding JU, Rathgeber J, Zenker D (1999) Prospective randomized and controlled study on solvent/detergent versus methylene blue/light virus-inactivated plasma. Transfusion 39(S10):23s. doi:10.1111/j.1537-2995.1999.tb05925.x
    • (1999) Transfusion , vol.39 , Issue.S10 , pp. 23s
    • Wieding, J.U.1    Rathgeber, J.2    Zenker, D.3
  • 79
    • 47749153754 scopus 로고    scopus 로고
    • Virus-inactivated—Plasmasafe: a one-year experience
    • PID: 19204766
    • De Silvestro G, Bagatella P, Tison T et al (2007) Virus-inactivated—Plasmasafe: a one-year experience. Blood Transfus 5:134–142
    • (2007) Blood Transfus , vol.5 , pp. 134-142
    • De Silvestro, G.1    Bagatella, P.2    Tison, T.3
  • 80
    • 33644652926 scopus 로고    scopus 로고
    • The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma
    • PID: 16512839
    • McCarthy LJ (2006) The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma. Br J Haematol 133:107
    • (2006) Br J Haematol , vol.133 , pp. 107
    • McCarthy, L.J.1
  • 81
    • 34547808148 scopus 로고    scopus 로고
    • Cryosupernatant and solvent detergent fresh frozen plasma (octaplas) usage in a single centre in acute thrombotic thrombocytopenic purpura
    • COI: 1:STN:280:DC%2BD2svmsFWmtg%3D%3D, PID: 17683359
    • Scully M, Longair I, Flynn M, Berryman J, Machin SJ (2007) Cryosupernatant and solvent detergent fresh frozen plasma (octaplas) usage in a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang 93:154–158
    • (2007) Vox Sang , vol.93 , pp. 154-158
    • Scully, M.1    Longair, I.2    Flynn, M.3    Berryman, J.4    Machin, S.J.5
  • 82
    • 77149138606 scopus 로고    scopus 로고
    • Efficacy and safety profile of solvent/detergent plasma in the treatment of acute thrombotic thrombocytopenic purpura: a single-center experience
    • PID: 20737012
    • Edel E, Al-Ali HK, Seeger S, Kauschat D, Matthes G (2010) Efficacy and safety profile of solvent/detergent plasma in the treatment of acute thrombotic thrombocytopenic purpura: a single-center experience. Transfus Med Hemother 37:13–19
    • (2010) Transfus Med Hemother , vol.37 , pp. 13-19
    • Edel, E.1    Al-Ali, H.K.2    Seeger, S.3    Kauschat, D.4    Matthes, G.5
  • 83
    • 79851483728 scopus 로고    scopus 로고
    • France: solvent/detergent plasma
    • AuBuchon JP, Prowse CV, (eds), AABB Press, Bethesda:
    • Andreu G (2010) France: solvent/detergent plasma. In: AuBuchon JP, Prowse CV (eds) Pathogen inactivation: the penultimate paradigm shift. AABB Press, Bethesda, pp 137–151
    • (2010) Pathogen inactivation: the penultimate paradigm shift , pp. 137-151
    • Andreu, G.1
  • 84
    • 79851472202 scopus 로고    scopus 로고
    • Introduction of octaplas in clinical use decreased the rate of serious adverse reactions
    • Krusius T, Auvinen M-K, Tuimala (2010) Introduction of octaplas in clinical use decreased the rate of serious adverse reactions. Vox Sang 99(Suppl 1):P-1018
    • (2010) Vox Sang , vol.99
    • Krusius, T.1    Auvinen, M.-K.2    Tuimala3
  • 85
    • 0031854171 scopus 로고    scopus 로고
    • Hemovigilance: clinical tolerance of solvent-detergent treated plasma
    • Baudoux E, Margraff U, Coenen A et al (1998) Hemovigilance: clinical tolerance of solvent-detergent treated plasma. Vox Sang 74Ssuppl 1):237-239
    • (1998) Vox Sang 74Ssuppl , vol.1 , pp. 237-239
    • Baudoux, E.1    Margraff, U.2    Coenen, A.3
  • 86
    • 84885419540 scopus 로고    scopus 로고
    • Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
    • PID: 24032719
    • Bolton-Maggs PH, Cohen H (2013) Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 163:303–314
    • (2013) Br J Haematol , vol.163 , pp. 303-314
    • Bolton-Maggs, P.H.1    Cohen, H.2
  • 87
    • 84939918482 scopus 로고    scopus 로고
    • Österreichisches Bundesinstitut für Gesundheitswesen (2004) Hämovigilanz Jahresbericht 2004. Accessed 18 February 2014
    • Österreichisches Bundesinstitut für Gesundheitswesen (2004) Hämovigilanz Jahresbericht 2004. http://www.goeg.at/cxdata/media/download/berichte/HaemJB_2004.pdf. Accessed 18 February 2014
  • 89
    • 84942949484 scopus 로고
    • Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply
    • COI: 1:STN:280:DyaK2M%2FhvV2huw%3D%3D, PID: 7933351
    • AuBuchon JP, Birkmeyer JD (1994) Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA 272:1210–1214
    • (1994) JAMA , vol.272 , pp. 1210-1214
    • AuBuchon, J.P.1    Birkmeyer, J.D.2
  • 90
    • 0032903262 scopus 로고    scopus 로고
    • Cost-effectiveness of transfusing virus inactivated plasma instead of standard plasma
    • COI: 1:STN:280:DyaK1M3mslShug%3D%3D, PID: 10335997
    • Pereira A (1999) Cost-effectiveness of transfusing virus inactivated plasma instead of standard plasma. Transfusion 39:479–487
    • (1999) Transfusion , vol.39 , pp. 479-487
    • Pereira, A.1
  • 91
    • 0033612672 scopus 로고    scopus 로고
    • Update of cost-effectiveness analysis for solvent-detergent-treated plasma
    • Jakson BR, AuBuchon JP, Birkmeyer JD (1999) Update of cost-effectiveness analysis for solvent-detergent-treated plasma. JAMA 282:329
    • (1999) JAMA , vol.282 , pp. 329
    • Jakson, B.R.1    AuBuchon, J.P.2    Birkmeyer, J.D.3
  • 92
    • 0041639518 scopus 로고    scopus 로고
    • Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma
    • COI: 1:STN:280:DC%2BD3szovV2isA%3D%3D, PID: 12925160
    • Riedler GF, Haycox AR, Duggan AK, Dakin HA (2003) Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma. Vox Sang 85:88–95
    • (2003) Vox Sang , vol.85 , pp. 88-95
    • Riedler, G.F.1    Haycox, A.R.2    Duggan, A.K.3    Dakin, H.A.4
  • 94
    • 84939918483 scopus 로고    scopus 로고
    • Membe SK, Coyle D, Husereau D, Cimon K, Tinmouth A, Normandin S (2009) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis. Accessed 17 February 2014
    • Membe SK, Coyle D, Husereau D, Cimon K, Tinmouth A, Normandin S (2009) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis. http://www.cadth.ca/media/pdf/I4002_Octaplas%20versus%20FFP_L4_e_April%202009.pdf. Accessed 17 February 2014


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.